EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 6 December 2018

News

EFPIA notes with concern the INTA Committee’s draft opinion on the SPC manufacturing waiver...
04 December 2018

Many of the medicines available to patients today and those in the R&D pipeline would not be there without the EU’s... Read more

Blogs

How to improve patient care by accelerating the development, delivery and uptake of personalised...
06 December 2018 - Ivana Cattaneo

Reflections from the European Congress on Personalised Medicine Read more

Data: our secret weapon in the war on cancer (Guest blog)
05 December 2018 - Victor Preckler

The digital revolution is coming for cancer – but only if we fix how we collect and use data Read more

100 years of protecting innovation in Poland. Until now...
06 December 2018 - Ania Jedrusik

Looking back at my country’s remarkable development after 1989, I hope that the Polish Government will stay on the right... Read more

Events

Building A Healthier Future For Europe
12 December 2018 (Press Club, Brussels)

The showcase of EFPIA and ITN #WeWontRest Film Read more

Symposium: Accessibility and Impact of High Value Medicines - Science, Patients & Politics
15 January 2019 (London)

A unique forum where advanced scientists, health authorities, patient advocates & industry decision-makers confront... Read more

The 3rd annual Patients as Partners Europe
28 January 2019 (London)

The only conference in Europe that demonstrates how to involve patients throughout the entire medicines development... Read more

22102018 Data Transparency Conference
12 February 2019 (Brussels)

Demystifying Clinical Data Transparency: Lessons learnt so far Read more

7th ACCELERATE Paediatric Oncology Conference
14 February 2019 (Steigenberger Wiltcher’s, Avenue Louise 71, Brussels, Belgium)

An international platform of all diverse stakeholders caring about accelerating new oncology drug development for children... Read more

ICHOM conference 2019
02 May 2019 (Rotterdam, The Netherlands)

The world-leading event for providers, life sciences and industry on value-based healthcare Read more

What we are reading

Romanian health minister: Prevention and innovative drugs to kill cancer
On 04 December 2018 (EurActiv)

In order to face the rising cancer incidence across Europe, governments should prioritise prevention policies, as well... Read more

Greek pharma boss: ‘We reached our limits, our sustainability is at stake’
On 04 December 2018 (EurActiv)

The Greek pharmaceutical industry has reached its limits due to a number of “unreasonable” burdens imposed by the government... Read more

Together we can change the future of cancer
On 03 December 2018 (EurActiv)

With momentum growing for a European Cancer Plan, there is a real opportunity to make a difference for cancer patients... Read more

The European Commission should shelve its patent law proposal
On 30 November 2018 (EurActiv)

The European Commission is considering an initiative that would permanently hobble the continent’s economy, writes Jan... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu